KinaSense
West Lafayette · Founded 2013
About KinaSense
Tyrosine kinase inhibitors (TKIs) are used to treat a variety of cancer types. The current diagnostic tools lack the predictive power to match the right patient with the right TKI. KinaSense is developing technologies that can be used to predict whether a given patient will benefit from a specific TKI.
Company Facts
- Founded: 2013
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: Less than $1M
- Total funding: $200.0K
- Last round: Grant (Mar 2016)
- Website: kinasense.com
- Phone: 2698705908
Social Profiles
Canonical: https://fsome.com/organization/kinasense-8269444 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.